Search Results 1111-1120 of 21676 for Inhibition

1. Immuno-Epigenetics: William A. Faubion Jr.

   In addition to these techniques, the lab is investigating clinically relevant epigenetic inhibitors, long noncoding RNAs (lncRNAs) and CRISPR-Cas9 technologies ...

2. Low Dose ColchicinE In PAtients With Peripheral Artery DiseasE To Address Residual Vascular Risk - Mayo Clinic

   ... inhibitors, azole antifungals, or macrolide antibiotics (with the exception of azithromycin) 8. Patients who are deemed unlikely to return for follow-up 9 ...

3. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

   Prior treatment with a known poly(ADP-ribose) polymerase (PARP) inhibitor; Heart-rate corrected QT interval (QTc) prolongation > 470 msec at screening; Known ...

4. David A. Wetter, M.D. - Doctors and Medical Staff - Mayo Clinic

   Paradoxical autoimmune side effects of tumor necrosis factor-alpha inhibitors, including psoriasis, lupus and vasculitis. Conditions treated · Dermatomyositis ...

5. Isocarboxazid (oral route) - Side effects & dosage - Mayo Clinic

   It belongs to the group of medicines called monoamine oxidase inhibitors (MAOI). This medicine works by blocking the action of a chemical substance known as ...

6. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

   Any prior systemic chemotherapy, small molecule inhibitors, immune checkpoint inhibitors, other monoclonal antibodies, antibody-drug conjugates ...

7. Immuno-Epigenetics: William A. Faubion Jr.

   In addition to these techniques, the lab is investigating clinically relevant epigenetic inhibitors, long noncoding RNAs (lncRNAs) and CRISPR-Cas9 technologies ...

8. Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic

   ... inhibitors also are coming out. ... Initial results reported in Japan showed that the combination of regorafenib, a multitargeted TKI, with PD-L1 inhibition can ...

9. Researchers look at possible link between low vitamin B12 and Parkinson's symptoms

   Cholinergic dysfunction may play a role in freezing of gait, and recent clinical trials suggest that anticholinesterase inhibitors, which increase acetylcholine ...

10. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    The U.S. Food and Drug Administration has approved the JAK inhibitor upadacitinib to treat Crohn's disease. JAK inhibitors are not recommended for use in ...